GlassScriptPhysician profile
Susan Bennett
NPI 1750799334
$2,864.63
in general payments reported to CMS, 2019-2025
18 companies · $1,097 in 2025
The $1,097 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $528 · 2023: $493 · 2024: $746 · 2025: $1,097.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,236.29 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $689.93 | 2023-2025 | Rybrevant, Erleada, Carvykti |
| Jazz Pharmaceuticals INC. | $295.42 | 2022-2025 | |
| Glaxosmithkline, LLC. | $255.88 | 2022-2025 | Ojjaara |
| Incyte Corporation | $199.94 | 2022-2024 | |
| Astellas Pharma US INC | $140.00 | 2025 | Vyloy |
| Astrazeneca Pharmaceuticals LP | $138.53 | 2022-2025 | Enhertu |
| Exelixis INC. | $125.00 | 2023 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2025 | Reblozyl |
| Beigene USA, INC. | $125.00 | 2023 | Brukinsa |
| Adc Therapeutics America, INC. | $125.00 | 2025 | |
| Stemline Therapeutics INC. | $125.00 | 2025 | Orserdu |
| Genzyme Corporation | $124.74 | 2022 | |
| Merck Sharp & Dohme LLC | $118.42 | 2024 | Keytruda |
| Novocure INC. | $96.00 | 2025 | Optune Lua (Novottf-200t) |
| Amgen INC. | $64.73 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $61.87 | 2024 | Trodelvy |
| Urgo Medical North America, LLC | $36.62 | 2023 | Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| Abbvie INC. | $17.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.